nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—ABCB1—melanoma	0.282	1	CbGaD
Fentanyl—CYP3A4—Temozolomide—melanoma	0.0817	0.226	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0525	0.145	CbGbCtD
Fentanyl—CYP3A7—Docetaxel—melanoma	0.0525	0.145	CbGbCtD
Fentanyl—ABCB1—Dactinomycin—melanoma	0.0496	0.137	CbGbCtD
Fentanyl—CYP3A4—Vemurafenib—melanoma	0.0447	0.124	CbGbCtD
Fentanyl—CYP3A5—Docetaxel—melanoma	0.0394	0.109	CbGbCtD
Fentanyl—ABCB1—Docetaxel—melanoma	0.0256	0.0709	CbGbCtD
Fentanyl—CYP3A4—Docetaxel—melanoma	0.0154	0.0425	CbGbCtD
Fentanyl—Quinapril—SLC15A2—melanoma	0.00121	0.3	CrCbGaD
Fentanyl—Benazepril—SLC15A2—melanoma	0.00105	0.261	CrCbGaD
Fentanyl—Alfentanil—ALB—melanoma	0.000344	0.0853	CrCbGaD
Fentanyl—Alfentanil—ABCB1—melanoma	0.000328	0.0814	CrCbGaD
Fentanyl—Anaemia—Dactinomycin—melanoma	0.00029	0.00107	CcSEcCtD
Fentanyl—Vomiting—Vemurafenib—melanoma	0.000288	0.00107	CcSEcCtD
Fentanyl—Alopecia—Temozolomide—melanoma	0.000288	0.00106	CcSEcCtD
Fentanyl—Chest pain—Bleomycin—melanoma	0.000286	0.00106	CcSEcCtD
Fentanyl—Myalgia—Bleomycin—melanoma	0.000286	0.00106	CcSEcCtD
Fentanyl—Abdominal pain upper—Docetaxel—melanoma	0.000286	0.00106	CcSEcCtD
Fentanyl—Orthostatic hypotension—Docetaxel—melanoma	0.000286	0.00106	CcSEcCtD
Fentanyl—Rash—Vemurafenib—melanoma	0.000286	0.00106	CcSEcCtD
Fentanyl—Mental disorder—Temozolomide—melanoma	0.000286	0.00106	CcSEcCtD
Fentanyl—Dermatitis—Vemurafenib—melanoma	0.000285	0.00106	CcSEcCtD
Fentanyl—Back pain—Carmustine—melanoma	0.000284	0.00105	CcSEcCtD
Fentanyl—Headache—Vemurafenib—melanoma	0.000284	0.00105	CcSEcCtD
Fentanyl—Erythema—Temozolomide—melanoma	0.000284	0.00105	CcSEcCtD
Fentanyl—Malnutrition—Temozolomide—melanoma	0.000284	0.00105	CcSEcCtD
Fentanyl—Breast disorder—Docetaxel—melanoma	0.000283	0.00105	CcSEcCtD
Fentanyl—Discomfort—Bleomycin—melanoma	0.000283	0.00105	CcSEcCtD
Fentanyl—Malaise—Dactinomycin—melanoma	0.000283	0.00105	CcSEcCtD
Fentanyl—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000282	0.00104	CcSEcCtD
Fentanyl—Leukopenia—Dactinomycin—melanoma	0.000281	0.00104	CcSEcCtD
Fentanyl—Nasopharyngitis—Docetaxel—melanoma	0.00028	0.00104	CcSEcCtD
Fentanyl—Dysgeusia—Temozolomide—melanoma	0.000278	0.00103	CcSEcCtD
Fentanyl—Confusional state—Bleomycin—melanoma	0.000277	0.00102	CcSEcCtD
Fentanyl—Vision blurred—Carmustine—melanoma	0.000277	0.00102	CcSEcCtD
Fentanyl—Tremor—Carmustine—melanoma	0.000275	0.00102	CcSEcCtD
Fentanyl—Anaphylactic shock—Bleomycin—melanoma	0.000275	0.00101	CcSEcCtD
Fentanyl—Oedema—Bleomycin—melanoma	0.000275	0.00101	CcSEcCtD
Fentanyl—Back pain—Temozolomide—melanoma	0.000274	0.00101	CcSEcCtD
Fentanyl—Infection—Bleomycin—melanoma	0.000273	0.00101	CcSEcCtD
Fentanyl—Anaemia—Carmustine—melanoma	0.000271	0.001	CcSEcCtD
Fentanyl—Dysphagia—Docetaxel—melanoma	0.000271	0.001	CcSEcCtD
Fentanyl—Agitation—Carmustine—melanoma	0.00027	0.000998	CcSEcCtD
Fentanyl—Nausea—Vemurafenib—melanoma	0.000269	0.000995	CcSEcCtD
Fentanyl—Thrombocytopenia—Bleomycin—melanoma	0.000269	0.000994	CcSEcCtD
Fentanyl—Vision blurred—Temozolomide—melanoma	0.000267	0.000989	CcSEcCtD
Fentanyl—Myalgia—Dactinomycin—melanoma	0.000267	0.000987	CcSEcCtD
Fentanyl—Bronchospasm—Docetaxel—melanoma	0.000266	0.000985	CcSEcCtD
Fentanyl—Tremor—Temozolomide—melanoma	0.000266	0.000983	CcSEcCtD
Fentanyl—Discomfort—Dactinomycin—melanoma	0.000264	0.000976	CcSEcCtD
Fentanyl—Angina pectoris—Docetaxel—melanoma	0.000264	0.000975	CcSEcCtD
Fentanyl—Ill-defined disorder—Temozolomide—melanoma	0.000263	0.000973	CcSEcCtD
Fentanyl—Leukopenia—Carmustine—melanoma	0.000263	0.000972	CcSEcCtD
Fentanyl—Anaemia—Temozolomide—melanoma	0.000262	0.00097	CcSEcCtD
Fentanyl—Anorexia—Bleomycin—melanoma	0.000262	0.000967	CcSEcCtD
Fentanyl—Agitation—Temozolomide—melanoma	0.000261	0.000964	CcSEcCtD
Fentanyl—Pancytopenia—Docetaxel—melanoma	0.000257	0.000951	CcSEcCtD
Fentanyl—Hypotension—Bleomycin—melanoma	0.000257	0.000948	CcSEcCtD
Fentanyl—Oedema—Dactinomycin—melanoma	0.000256	0.000947	CcSEcCtD
Fentanyl—Malaise—Temozolomide—melanoma	0.000256	0.000946	CcSEcCtD
Fentanyl—Astemizole—ABCB1—melanoma	0.000255	0.0633	CrCbGaD
Fentanyl—Vertigo—Temozolomide—melanoma	0.000255	0.000943	CcSEcCtD
Fentanyl—Convulsion—Carmustine—melanoma	0.000254	0.000941	CcSEcCtD
Fentanyl—Infection—Dactinomycin—melanoma	0.000254	0.00094	CcSEcCtD
Fentanyl—Leukopenia—Temozolomide—melanoma	0.000254	0.000939	CcSEcCtD
Fentanyl—Hypertension—Carmustine—melanoma	0.000254	0.000937	CcSEcCtD
Fentanyl—Neutropenia—Docetaxel—melanoma	0.000253	0.000936	CcSEcCtD
Fentanyl—Palpitations—Temozolomide—melanoma	0.000251	0.000927	CcSEcCtD
Fentanyl—Thrombocytopenia—Dactinomycin—melanoma	0.000251	0.000927	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Bleomycin—melanoma	0.00025	0.000925	CcSEcCtD
Fentanyl—Chest pain—Carmustine—melanoma	0.00025	0.000924	CcSEcCtD
Fentanyl—Myalgia—Carmustine—melanoma	0.00025	0.000924	CcSEcCtD
Fentanyl—Anxiety—Carmustine—melanoma	0.000249	0.000921	CcSEcCtD
Fentanyl—Cough—Temozolomide—melanoma	0.000248	0.000915	CcSEcCtD
Fentanyl—Paraesthesia—Bleomycin—melanoma	0.000247	0.000911	CcSEcCtD
Fentanyl—Weight increased—Docetaxel—melanoma	0.000246	0.000911	CcSEcCtD
Fentanyl—Convulsion—Temozolomide—melanoma	0.000246	0.000909	CcSEcCtD
Fentanyl—Weight decreased—Docetaxel—melanoma	0.000245	0.000906	CcSEcCtD
Fentanyl—Hypertension—Temozolomide—melanoma	0.000245	0.000906	CcSEcCtD
Fentanyl—Dyspnoea—Bleomycin—melanoma	0.000245	0.000905	CcSEcCtD
Fentanyl—Anorexia—Dactinomycin—melanoma	0.000244	0.000902	CcSEcCtD
Fentanyl—Pneumonia—Docetaxel—melanoma	0.000243	0.000898	CcSEcCtD
Fentanyl—Confusional state—Carmustine—melanoma	0.000242	0.000893	CcSEcCtD
Fentanyl—Myalgia—Temozolomide—melanoma	0.000242	0.000893	CcSEcCtD
Fentanyl—Arthralgia—Temozolomide—melanoma	0.000242	0.000893	CcSEcCtD
Fentanyl—Infestation—Docetaxel—melanoma	0.000241	0.000893	CcSEcCtD
Fentanyl—Infestation NOS—Docetaxel—melanoma	0.000241	0.000893	CcSEcCtD
Fentanyl—Anxiety—Temozolomide—melanoma	0.000241	0.00089	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00024	0.000887	CcSEcCtD
Fentanyl—Oedema—Carmustine—melanoma	0.00024	0.000886	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000239	0.000885	CcSEcCtD
Fentanyl—Discomfort—Temozolomide—melanoma	0.000239	0.000882	CcSEcCtD
Fentanyl—Decreased appetite—Bleomycin—melanoma	0.000239	0.000882	CcSEcCtD
Fentanyl—Infection—Carmustine—melanoma	0.000238	0.00088	CcSEcCtD
Fentanyl—Renal failure—Docetaxel—melanoma	0.000237	0.000878	CcSEcCtD
Fentanyl—Neuropathy peripheral—Docetaxel—melanoma	0.000237	0.000875	CcSEcCtD
Fentanyl—Dry mouth—Temozolomide—melanoma	0.000236	0.000873	CcSEcCtD
Fentanyl—Jaundice—Docetaxel—melanoma	0.000235	0.00087	CcSEcCtD
Fentanyl—Stomatitis—Docetaxel—melanoma	0.000235	0.00087	CcSEcCtD
Fentanyl—Pain—Bleomycin—melanoma	0.000235	0.000868	CcSEcCtD
Fentanyl—Conjunctivitis—Docetaxel—melanoma	0.000235	0.000868	CcSEcCtD
Fentanyl—Thrombocytopenia—Carmustine—melanoma	0.000235	0.000867	CcSEcCtD
Fentanyl—Tachycardia—Carmustine—melanoma	0.000234	0.000865	CcSEcCtD
Fentanyl—Confusional state—Temozolomide—melanoma	0.000234	0.000863	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000233	0.000862	CcSEcCtD
Fentanyl—Anaphylactic shock—Temozolomide—melanoma	0.000232	0.000856	CcSEcCtD
Fentanyl—Oedema—Temozolomide—melanoma	0.000232	0.000856	CcSEcCtD
Fentanyl—Infection—Temozolomide—melanoma	0.00023	0.000851	CcSEcCtD
Fentanyl—Anorexia—Carmustine—melanoma	0.000228	0.000845	CcSEcCtD
Fentanyl—Hepatobiliary disease—Docetaxel—melanoma	0.000228	0.000844	CcSEcCtD
Fentanyl—Epistaxis—Docetaxel—melanoma	0.000228	0.000842	CcSEcCtD
Fentanyl—Nervous system disorder—Temozolomide—melanoma	0.000227	0.00084	CcSEcCtD
Fentanyl—Thrombocytopenia—Temozolomide—melanoma	0.000227	0.000838	CcSEcCtD
Fentanyl—Feeling abnormal—Bleomycin—melanoma	0.000226	0.000836	CcSEcCtD
Fentanyl—Skin disorder—Temozolomide—melanoma	0.000225	0.000832	CcSEcCtD
Fentanyl—Hypotension—Carmustine—melanoma	0.000224	0.000828	CcSEcCtD
Fentanyl—Hyperhidrosis—Temozolomide—melanoma	0.000224	0.000828	CcSEcCtD
Fentanyl—Decreased appetite—Dactinomycin—melanoma	0.000223	0.000823	CcSEcCtD
Fentanyl—Fatigue—Dactinomycin—melanoma	0.000221	0.000816	CcSEcCtD
Fentanyl—Anorexia—Temozolomide—melanoma	0.000221	0.000816	CcSEcCtD
Fentanyl—Pain—Dactinomycin—melanoma	0.000219	0.000809	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Carmustine—melanoma	0.000218	0.000807	CcSEcCtD
Fentanyl—Urticaria—Bleomycin—melanoma	0.000218	0.000806	CcSEcCtD
Fentanyl—Haemoglobin—Docetaxel—melanoma	0.000218	0.000805	CcSEcCtD
Fentanyl—Rhinitis—Docetaxel—melanoma	0.000217	0.000803	CcSEcCtD
Fentanyl—Body temperature increased—Bleomycin—melanoma	0.000217	0.000802	CcSEcCtD
Fentanyl—Haemorrhage—Docetaxel—melanoma	0.000217	0.000801	CcSEcCtD
Fentanyl—Insomnia—Carmustine—melanoma	0.000217	0.000801	CcSEcCtD
Fentanyl—Hypoaesthesia—Docetaxel—melanoma	0.000216	0.000797	CcSEcCtD
Fentanyl—Paraesthesia—Carmustine—melanoma	0.000215	0.000796	CcSEcCtD
Fentanyl—Pharyngitis—Docetaxel—melanoma	0.000215	0.000795	CcSEcCtD
Fentanyl—Urinary tract disorder—Docetaxel—melanoma	0.000214	0.000791	CcSEcCtD
Fentanyl—Dyspnoea—Carmustine—melanoma	0.000214	0.00079	CcSEcCtD
Fentanyl—Oedema peripheral—Docetaxel—melanoma	0.000214	0.000789	CcSEcCtD
Fentanyl—Somnolence—Carmustine—melanoma	0.000213	0.000788	CcSEcCtD
Fentanyl—Connective tissue disorder—Docetaxel—melanoma	0.000213	0.000788	CcSEcCtD
Fentanyl—Urethral disorder—Docetaxel—melanoma	0.000213	0.000786	CcSEcCtD
Fentanyl—Feeling abnormal—Dactinomycin—melanoma	0.000211	0.00078	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Temozolomide—melanoma	0.000211	0.00078	CcSEcCtD
Fentanyl—Insomnia—Temozolomide—melanoma	0.000209	0.000774	CcSEcCtD
Fentanyl—Gastrointestinal pain—Dactinomycin—melanoma	0.000209	0.000774	CcSEcCtD
Fentanyl—Visual impairment—Docetaxel—melanoma	0.000209	0.000772	CcSEcCtD
Fentanyl—Decreased appetite—Carmustine—melanoma	0.000208	0.00077	CcSEcCtD
Fentanyl—Paraesthesia—Temozolomide—melanoma	0.000208	0.000769	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Carmustine—melanoma	0.000207	0.000765	CcSEcCtD
Fentanyl—Dyspnoea—Temozolomide—melanoma	0.000206	0.000763	CcSEcCtD
Fentanyl—Somnolence—Temozolomide—melanoma	0.000206	0.000761	CcSEcCtD
Fentanyl—Erythema multiforme—Docetaxel—melanoma	0.000205	0.000758	CcSEcCtD
Fentanyl—Constipation—Carmustine—melanoma	0.000205	0.000758	CcSEcCtD
Fentanyl—Pain—Carmustine—melanoma	0.000205	0.000758	CcSEcCtD
Fentanyl—Dyspepsia—Temozolomide—melanoma	0.000204	0.000754	CcSEcCtD
Fentanyl—Eye disorder—Docetaxel—melanoma	0.000203	0.000749	CcSEcCtD
Fentanyl—Body temperature increased—Dactinomycin—melanoma	0.000202	0.000748	CcSEcCtD
Fentanyl—Abdominal pain—Dactinomycin—melanoma	0.000202	0.000748	CcSEcCtD
Fentanyl—Hypersensitivity—Bleomycin—melanoma	0.000202	0.000748	CcSEcCtD
Fentanyl—Decreased appetite—Temozolomide—melanoma	0.000201	0.000744	CcSEcCtD
Fentanyl—Flushing—Docetaxel—melanoma	0.000201	0.000744	CcSEcCtD
Fentanyl—Cardiac disorder—Docetaxel—melanoma	0.000201	0.000744	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Temozolomide—melanoma	0.0002	0.000739	CcSEcCtD
Fentanyl—Fatigue—Temozolomide—melanoma	0.0002	0.000738	CcSEcCtD
Fentanyl—Constipation—Temozolomide—melanoma	0.000198	0.000732	CcSEcCtD
Fentanyl—Pain—Temozolomide—melanoma	0.000198	0.000732	CcSEcCtD
Fentanyl—Feeling abnormal—Carmustine—melanoma	0.000197	0.00073	CcSEcCtD
Fentanyl—Asthenia—Bleomycin—melanoma	0.000197	0.000728	CcSEcCtD
Fentanyl—Angiopathy—Docetaxel—melanoma	0.000197	0.000727	CcSEcCtD
Fentanyl—Gastrointestinal pain—Carmustine—melanoma	0.000196	0.000724	CcSEcCtD
Fentanyl—Immune system disorder—Docetaxel—melanoma	0.000196	0.000724	CcSEcCtD
Fentanyl—Mediastinal disorder—Docetaxel—melanoma	0.000195	0.000722	CcSEcCtD
Fentanyl—Chills—Docetaxel—melanoma	0.000195	0.000719	CcSEcCtD
Fentanyl—Pruritus—Bleomycin—melanoma	0.000194	0.000718	CcSEcCtD
Fentanyl—Arrhythmia—Docetaxel—melanoma	0.000194	0.000716	CcSEcCtD
Fentanyl—Alopecia—Docetaxel—melanoma	0.000192	0.000708	CcSEcCtD
Fentanyl—Feeling abnormal—Temozolomide—melanoma	0.000191	0.000706	CcSEcCtD
Fentanyl—Mental disorder—Docetaxel—melanoma	0.00019	0.000702	CcSEcCtD
Fentanyl—Abdominal pain—Carmustine—melanoma	0.000189	0.0007	CcSEcCtD
Fentanyl—Body temperature increased—Carmustine—melanoma	0.000189	0.0007	CcSEcCtD
Fentanyl—Gastrointestinal pain—Temozolomide—melanoma	0.000189	0.0007	CcSEcCtD
Fentanyl—Malnutrition—Docetaxel—melanoma	0.000189	0.000698	CcSEcCtD
Fentanyl—Erythema—Docetaxel—melanoma	0.000189	0.000698	CcSEcCtD
Fentanyl—Hypersensitivity—Dactinomycin—melanoma	0.000189	0.000697	CcSEcCtD
Fentanyl—Dysgeusia—Docetaxel—melanoma	0.000185	0.000683	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS2—melanoma	0.000185	0.0457	CrCbGaD
Fentanyl—Urticaria—Temozolomide—melanoma	0.000184	0.00068	CcSEcCtD
Fentanyl—Asthenia—Dactinomycin—melanoma	0.000184	0.000679	CcSEcCtD
Fentanyl—Abdominal pain—Temozolomide—melanoma	0.000183	0.000677	CcSEcCtD
Fentanyl—Body temperature increased—Temozolomide—melanoma	0.000183	0.000677	CcSEcCtD
Fentanyl—Back pain—Docetaxel—melanoma	0.000183	0.000675	CcSEcCtD
Fentanyl—Fexofenadine—ABCB1—melanoma	0.000182	0.0451	CrCbGaD
Fentanyl—Muscle spasms—Docetaxel—melanoma	0.000181	0.000671	CcSEcCtD
Fentanyl—Hypersensitivity—Carmustine—melanoma	0.000177	0.000653	CcSEcCtD
Fentanyl—Diarrhoea—Dactinomycin—melanoma	0.000175	0.000648	CcSEcCtD
Fentanyl—Vomiting—Bleomycin—melanoma	0.000175	0.000645	CcSEcCtD
Fentanyl—Anaemia—Docetaxel—melanoma	0.000174	0.000645	CcSEcCtD
Fentanyl—Rash—Bleomycin—melanoma	0.000173	0.00064	CcSEcCtD
Fentanyl—Dermatitis—Bleomycin—melanoma	0.000173	0.000639	CcSEcCtD
Fentanyl—Asthenia—Carmustine—melanoma	0.000172	0.000636	CcSEcCtD
Fentanyl—Hypersensitivity—Temozolomide—melanoma	0.000171	0.000631	CcSEcCtD
Fentanyl—Syncope—Docetaxel—melanoma	0.000169	0.000626	CcSEcCtD
Fentanyl—Leukopenia—Docetaxel—melanoma	0.000169	0.000624	CcSEcCtD
Fentanyl—Palpitations—Docetaxel—melanoma	0.000167	0.000617	CcSEcCtD
Fentanyl—Asthenia—Temozolomide—melanoma	0.000166	0.000614	CcSEcCtD
Fentanyl—Loss of consciousness—Docetaxel—melanoma	0.000166	0.000613	CcSEcCtD
Fentanyl—Cough—Docetaxel—melanoma	0.000165	0.000609	CcSEcCtD
Fentanyl—Diarrhoea—Carmustine—melanoma	0.000164	0.000606	CcSEcCtD
Fentanyl—Pruritus—Temozolomide—melanoma	0.000164	0.000606	CcSEcCtD
Fentanyl—Convulsion—Docetaxel—melanoma	0.000164	0.000604	CcSEcCtD
Fentanyl—Nausea—Bleomycin—melanoma	0.000163	0.000603	CcSEcCtD
Fentanyl—Hypertension—Docetaxel—melanoma	0.000163	0.000602	CcSEcCtD
Fentanyl—Vomiting—Dactinomycin—melanoma	0.000163	0.000602	CcSEcCtD
Fentanyl—Rash—Dactinomycin—melanoma	0.000161	0.000597	CcSEcCtD
Fentanyl—Chest pain—Docetaxel—melanoma	0.000161	0.000594	CcSEcCtD
Fentanyl—Arthralgia—Docetaxel—melanoma	0.000161	0.000594	CcSEcCtD
Fentanyl—Myalgia—Docetaxel—melanoma	0.000161	0.000594	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00016	0.00059	CcSEcCtD
Fentanyl—Dizziness—Carmustine—melanoma	0.000158	0.000586	CcSEcCtD
Fentanyl—Diarrhoea—Temozolomide—melanoma	0.000158	0.000586	CcSEcCtD
Fentanyl—Dry mouth—Docetaxel—melanoma	0.000157	0.000581	CcSEcCtD
Fentanyl—Confusional state—Docetaxel—melanoma	0.000155	0.000574	CcSEcCtD
Fentanyl—Oedema—Docetaxel—melanoma	0.000154	0.000569	CcSEcCtD
Fentanyl—Anaphylactic shock—Docetaxel—melanoma	0.000154	0.000569	CcSEcCtD
Fentanyl—Dizziness—Temozolomide—melanoma	0.000153	0.000566	CcSEcCtD
Fentanyl—Infection—Docetaxel—melanoma	0.000153	0.000566	CcSEcCtD
Fentanyl—Vomiting—Carmustine—melanoma	0.000152	0.000563	CcSEcCtD
Fentanyl—Nausea—Dactinomycin—melanoma	0.000152	0.000562	CcSEcCtD
Fentanyl—Shock—Docetaxel—melanoma	0.000152	0.00056	CcSEcCtD
Fentanyl—Rash—Carmustine—melanoma	0.000151	0.000559	CcSEcCtD
Fentanyl—Nervous system disorder—Docetaxel—melanoma	0.000151	0.000558	CcSEcCtD
Fentanyl—Dermatitis—Carmustine—melanoma	0.000151	0.000558	CcSEcCtD
Fentanyl—Thrombocytopenia—Docetaxel—melanoma	0.000151	0.000557	CcSEcCtD
Fentanyl—Tachycardia—Docetaxel—melanoma	0.00015	0.000556	CcSEcCtD
Fentanyl—Headache—Carmustine—melanoma	0.00015	0.000555	CcSEcCtD
Fentanyl—Skin disorder—Docetaxel—melanoma	0.00015	0.000553	CcSEcCtD
Fentanyl—Vomiting—Temozolomide—melanoma	0.000147	0.000544	CcSEcCtD
Fentanyl—Anorexia—Docetaxel—melanoma	0.000147	0.000543	CcSEcCtD
Fentanyl—Propafenone—ABCB1—melanoma	0.000147	0.0363	CrCbGaD
Fentanyl—Rash—Temozolomide—melanoma	0.000146	0.00054	CcSEcCtD
Fentanyl—Dermatitis—Temozolomide—melanoma	0.000146	0.000539	CcSEcCtD
Fentanyl—Headache—Temozolomide—melanoma	0.000145	0.000536	CcSEcCtD
Fentanyl—Hypotension—Docetaxel—melanoma	0.000144	0.000532	CcSEcCtD
Fentanyl—Nausea—Carmustine—melanoma	0.000142	0.000526	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Docetaxel—melanoma	0.00014	0.000519	CcSEcCtD
Fentanyl—Insomnia—Docetaxel—melanoma	0.000139	0.000515	CcSEcCtD
Fentanyl—Paraesthesia—Docetaxel—melanoma	0.000138	0.000511	CcSEcCtD
Fentanyl—Nausea—Temozolomide—melanoma	0.000138	0.000509	CcSEcCtD
Fentanyl—Dyspnoea—Docetaxel—melanoma	0.000137	0.000508	CcSEcCtD
Fentanyl—Somnolence—Docetaxel—melanoma	0.000137	0.000506	CcSEcCtD
Fentanyl—Dyspepsia—Docetaxel—melanoma	0.000136	0.000501	CcSEcCtD
Fentanyl—Decreased appetite—Docetaxel—melanoma	0.000134	0.000495	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Docetaxel—melanoma	0.000133	0.000492	CcSEcCtD
Fentanyl—Fatigue—Docetaxel—melanoma	0.000133	0.000491	CcSEcCtD
Fentanyl—Constipation—Docetaxel—melanoma	0.000132	0.000487	CcSEcCtD
Fentanyl—Pain—Docetaxel—melanoma	0.000132	0.000487	CcSEcCtD
Fentanyl—Bepridil—ABCB1—melanoma	0.000131	0.0324	CrCbGaD
Fentanyl—Feeling abnormal—Docetaxel—melanoma	0.000127	0.000469	CcSEcCtD
Fentanyl—Gastrointestinal pain—Docetaxel—melanoma	0.000126	0.000466	CcSEcCtD
Fentanyl—Body temperature increased—Docetaxel—melanoma	0.000122	0.00045	CcSEcCtD
Fentanyl—Abdominal pain—Docetaxel—melanoma	0.000122	0.00045	CcSEcCtD
Fentanyl—Loperamide—ABCB1—melanoma	0.000116	0.0287	CrCbGaD
Fentanyl—Hypersensitivity—Docetaxel—melanoma	0.000113	0.000419	CcSEcCtD
Fentanyl—Asthenia—Docetaxel—melanoma	0.000111	0.000409	CcSEcCtD
Fentanyl—Pruritus—Docetaxel—melanoma	0.000109	0.000403	CcSEcCtD
Fentanyl—Diarrhoea—Docetaxel—melanoma	0.000105	0.00039	CcSEcCtD
Fentanyl—Dizziness—Docetaxel—melanoma	0.000102	0.000377	CcSEcCtD
Fentanyl—Vomiting—Docetaxel—melanoma	9.79e-05	0.000362	CcSEcCtD
Fentanyl—Rash—Docetaxel—melanoma	9.71e-05	0.000359	CcSEcCtD
Fentanyl—Dermatitis—Docetaxel—melanoma	9.7e-05	0.000359	CcSEcCtD
Fentanyl—Headache—Docetaxel—melanoma	9.65e-05	0.000357	CcSEcCtD
Fentanyl—Nausea—Docetaxel—melanoma	9.15e-05	0.000338	CcSEcCtD
Fentanyl—Methadone—ABCB1—melanoma	8.24e-05	0.0204	CrCbGaD
Fentanyl—OPRK1—Signaling Pathways—RAC1—melanoma	1.61e-05	0.000197	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH1—melanoma	1.59e-05	0.000194	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC6A11—melanoma	1.58e-05	0.000193	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIP4K2A—melanoma	1.58e-05	0.000193	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—FASN—melanoma	1.58e-05	0.000193	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CD86—melanoma	1.58e-05	0.000193	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—melanoma	1.58e-05	0.000193	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.57e-05	0.000192	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EDN1—melanoma	1.57e-05	0.000192	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC5A5—melanoma	1.56e-05	0.00019	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CD80—melanoma	1.55e-05	0.00019	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KIT—melanoma	1.55e-05	0.00019	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APC—melanoma	1.55e-05	0.00019	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CG—melanoma	1.55e-05	0.00019	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—NRAS—melanoma	1.55e-05	0.00019	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HIF1A—melanoma	1.54e-05	0.000189	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTAP—melanoma	1.54e-05	0.000188	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGF—melanoma	1.53e-05	0.000188	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CSF2—melanoma	1.53e-05	0.000187	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGF1—melanoma	1.53e-05	0.000187	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—VCAN—melanoma	1.53e-05	0.000187	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PRKCA—melanoma	1.51e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2—melanoma	1.51e-05	0.000184	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNAQ—melanoma	1.5e-05	0.000184	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CD44—melanoma	1.5e-05	0.000184	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—E2F1—melanoma	1.5e-05	0.000183	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ERCC2—melanoma	1.5e-05	0.000183	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CB—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—MAPK3—melanoma	1.49e-05	0.000182	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PDGFRA—melanoma	1.48e-05	0.000181	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KDR—melanoma	1.48e-05	0.000181	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCA—melanoma	1.47e-05	0.000179	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ITGB3—melanoma	1.47e-05	0.000179	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BRAF—melanoma	1.46e-05	0.000178	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1B1—melanoma	1.44e-05	0.000176	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SPP1—melanoma	1.44e-05	0.000176	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAP2K2—melanoma	1.44e-05	0.000175	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—melanoma	1.43e-05	0.000175	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FN1—melanoma	1.42e-05	0.000174	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—melanoma	1.42e-05	0.000174	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—MAPK1—melanoma	1.41e-05	0.000173	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—melanoma	1.41e-05	0.000173	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH1—melanoma	1.39e-05	0.00017	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAP2K1—melanoma	1.37e-05	0.000168	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LUM—melanoma	1.37e-05	0.000168	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PHGDH—melanoma	1.37e-05	0.000168	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—melanoma	1.37e-05	0.000167	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TERT—melanoma	1.36e-05	0.000167	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CD—melanoma	1.36e-05	0.000167	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CD80—melanoma	1.36e-05	0.000167	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAC1—melanoma	1.36e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APC—melanoma	1.36e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CG—melanoma	1.36e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KIT—melanoma	1.36e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—NRAS—melanoma	1.36e-05	0.000166	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	1.35e-05	0.000165	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGF—melanoma	1.35e-05	0.000164	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HPSE—melanoma	1.34e-05	0.000164	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—KRAS—melanoma	1.34e-05	0.000163	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.32e-05	0.000162	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CUBN—melanoma	1.32e-05	0.000161	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGF2—melanoma	1.31e-05	0.00016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—melanoma	1.31e-05	0.00016	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MAPK3—melanoma	1.3e-05	0.000159	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP17A1—melanoma	1.29e-05	0.000158	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BRAF—melanoma	1.28e-05	0.000156	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BSG—melanoma	1.27e-05	0.000156	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CSPG4—melanoma	1.27e-05	0.000156	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SDHD—melanoma	1.27e-05	0.000156	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—melanoma	1.25e-05	0.000153	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—melanoma	1.25e-05	0.000152	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MAPK1—melanoma	1.24e-05	0.000152	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—melanoma	1.24e-05	0.000152	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPAM—melanoma	1.23e-05	0.000151	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—melanoma	1.23e-05	0.00015	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MDM2—melanoma	1.22e-05	0.000149	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNA11—melanoma	1.22e-05	0.000149	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ERBB2—melanoma	1.2e-05	0.000147	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAP2K1—melanoma	1.2e-05	0.000147	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FN1—melanoma	1.2e-05	0.000147	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CD—melanoma	1.2e-05	0.000146	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.2e-05	0.000146	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—FASN—melanoma	1.19e-05	0.000146	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CB—melanoma	1.19e-05	0.000145	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCB1—melanoma	1.19e-05	0.000145	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	1.18e-05	0.000145	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—melanoma	1.18e-05	0.000145	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH1—melanoma	1.18e-05	0.000144	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC5A5—melanoma	1.17e-05	0.000144	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—KRAS—melanoma	1.17e-05	0.000143	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CD80—melanoma	1.15e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—melanoma	1.15e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APC—melanoma	1.15e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KIT—melanoma	1.15e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—NRAS—melanoma	1.15e-05	0.000141	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGF2—melanoma	1.15e-05	0.00014	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—melanoma	1.14e-05	0.00014	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—melanoma	1.14e-05	0.00014	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGF—melanoma	1.14e-05	0.000139	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HRAS—melanoma	1.14e-05	0.000139	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNAQ—melanoma	1.13e-05	0.000139	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CD44—melanoma	1.13e-05	0.000139	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1B—melanoma	1.12e-05	0.000136	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—melanoma	1.1e-05	0.000135	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK3—melanoma	1.1e-05	0.000135	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—melanoma	1.09e-05	0.000134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—melanoma	1.09e-05	0.000134	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PRKCA—melanoma	1.09e-05	0.000133	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1B1—melanoma	1.09e-05	0.000133	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—melanoma	1.09e-05	0.000133	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ERCC2—melanoma	1.08e-05	0.000132	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—melanoma	1.08e-05	0.000132	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—melanoma	1.08e-05	0.000132	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MDM2—melanoma	1.07e-05	0.000131	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—melanoma	1.06e-05	0.00013	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ERBB2—melanoma	1.06e-05	0.000129	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CTNNB1—melanoma	1.05e-05	0.000129	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—melanoma	1.05e-05	0.000129	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLA2G6—melanoma	1.05e-05	0.000128	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK1—melanoma	1.05e-05	0.000128	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—melanoma	1.05e-05	0.000128	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CB—melanoma	1.04e-05	0.000127	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CD—melanoma	1.04e-05	0.000127	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—melanoma	1.03e-05	0.000126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1A—melanoma	1.03e-05	0.000126	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PTEN—melanoma	1.03e-05	0.000126	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—melanoma	1.03e-05	0.000125	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NFKB1—melanoma	1.02e-05	0.000125	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAP2K1—melanoma	1.02e-05	0.000124	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CD—melanoma	1.01e-05	0.000124	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—melanoma	1e-05	0.000123	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—melanoma	1e-05	0.000122	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	1e-05	0.000122	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HRAS—melanoma	9.95e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—KRAS—melanoma	9.9e-06	0.000121	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1B—melanoma	9.79e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGF2—melanoma	9.68e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—melanoma	9.68e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—melanoma	9.59e-06	0.000117	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—melanoma	9.58e-06	0.000117	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—melanoma	9.53e-06	0.000116	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—VCAN—melanoma	9.43e-06	0.000115	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—melanoma	9.33e-06	0.000114	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—melanoma	9.28e-06	0.000113	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNB1—melanoma	9.24e-06	0.000113	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—melanoma	9.19e-06	0.000112	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NRAS—melanoma	9.17e-06	0.000112	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—melanoma	9.09e-06	0.000111	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CB—melanoma	9.06e-06	0.000111	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—melanoma	9.06e-06	0.000111	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MDM2—melanoma	9.06e-06	0.000111	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1A—melanoma	9.03e-06	0.00011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTEN—melanoma	9.01e-06	0.00011	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—melanoma	8.98e-06	0.00011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFKB1—melanoma	8.97e-06	0.00011	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ERBB2—melanoma	8.93e-06	0.000109	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CB—melanoma	8.81e-06	0.000108	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—melanoma	8.79e-06	0.000107	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK3—melanoma	8.78e-06	0.000107	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—melanoma	8.55e-06	0.000105	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—melanoma	8.54e-06	0.000104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—melanoma	8.47e-06	0.000104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HRAS—melanoma	8.41e-06	0.000103	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK1—melanoma	8.35e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—melanoma	8.35e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1B—melanoma	8.27e-06	0.000101	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—melanoma	8.25e-06	0.000101	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PRKCA—melanoma	8.24e-06	0.000101	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—melanoma	8.18e-06	0.0001	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ERCC2—melanoma	8.17e-06	9.99e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—melanoma	8.14e-06	9.95e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—melanoma	8.11e-06	9.91e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—melanoma	8.09e-06	9.89e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—melanoma	8.06e-06	9.85e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—melanoma	8.05e-06	9.84e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NRAS—melanoma	8.04e-06	9.83e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP17A1—melanoma	7.96e-06	9.73e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KRAS—melanoma	7.89e-06	9.65e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—melanoma	7.89e-06	9.65e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTEN—melanoma	7.83e-06	9.58e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNB1—melanoma	7.81e-06	9.55e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK3—melanoma	7.7e-06	9.41e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—melanoma	7.66e-06	9.36e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1A—melanoma	7.63e-06	9.33e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTEN—melanoma	7.61e-06	9.31e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKB1—melanoma	7.58e-06	9.26e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CD—melanoma	7.52e-06	9.19e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNA11—melanoma	7.51e-06	9.19e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—melanoma	7.49e-06	9.15e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—melanoma	7.43e-06	9.08e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—melanoma	7.42e-06	9.07e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FASN—melanoma	7.35e-06	8.99e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK1—melanoma	7.32e-06	8.96e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—melanoma	7.32e-06	8.95e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—melanoma	7.25e-06	8.86e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC5A5—melanoma	7.23e-06	8.84e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—melanoma	7.01e-06	8.57e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNAQ—melanoma	6.98e-06	8.54e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CD44—melanoma	6.98e-06	8.54e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KRAS—melanoma	6.92e-06	8.46e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—melanoma	6.88e-06	8.41e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—melanoma	6.81e-06	8.33e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NRAS—melanoma	6.79e-06	8.31e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HRAS—melanoma	6.71e-06	8.2e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1B1—melanoma	6.7e-06	8.19e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CB—melanoma	6.55e-06	8.01e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK3—melanoma	6.51e-06	7.95e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—melanoma	6.49e-06	7.94e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—melanoma	6.45e-06	7.89e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—melanoma	6.42e-06	7.85e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—melanoma	6.36e-06	7.77e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—melanoma	6.33e-06	7.74e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—melanoma	6.23e-06	7.61e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK1—melanoma	6.19e-06	7.57e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—melanoma	6.19e-06	7.57e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—melanoma	6.15e-06	7.52e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—melanoma	5.92e-06	7.24e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HRAS—melanoma	5.88e-06	7.19e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KRAS—melanoma	5.85e-06	7.15e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CD—melanoma	5.67e-06	6.93e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTEN—melanoma	5.66e-06	6.92e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—melanoma	5.63e-06	6.88e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—melanoma	5.6e-06	6.85e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—melanoma	5.53e-06	6.76e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCB1—melanoma	5.51e-06	6.74e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—melanoma	5.37e-06	6.57e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—melanoma	5.2e-06	6.35e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—melanoma	5.19e-06	6.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PRKCA—melanoma	5.08e-06	6.2e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ERCC2—melanoma	5.03e-06	6.15e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HRAS—melanoma	4.97e-06	6.08e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CB—melanoma	4.94e-06	6.04e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—melanoma	4.9e-06	5.99e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—melanoma	4.76e-06	5.82e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—melanoma	4.51e-06	5.52e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—melanoma	4.39e-06	5.37e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTEN—melanoma	4.27e-06	5.22e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—melanoma	3.99e-06	4.88e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—melanoma	3.98e-06	4.86e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—melanoma	3.84e-06	4.69e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CD—melanoma	3.49e-06	4.27e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—melanoma	3.45e-06	4.22e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—melanoma	3.26e-06	3.99e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CB—melanoma	3.05e-06	3.72e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—melanoma	3.02e-06	3.69e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—melanoma	3.01e-06	3.68e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTEN—melanoma	2.63e-06	3.22e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—melanoma	2.46e-06	3.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—melanoma	1.86e-06	2.27e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—melanoma	1.52e-06	1.85e-05	CbGpPWpGaD
